These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 30307637)

  • 1. In vivo and in vitro assessment of mirtazapine pharmacokinetics in cats with liver disease.
    Fitzpatrick RL; Quimby JM; Benson KK; Ramirez D; Sieberg LG; Wittenburg LA; Gustafson DL
    J Vet Intern Med; 2018 Nov; 32(6):1951-1957. PubMed ID: 30307637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the pharmacokinetics and pharmacodynamics of mirtazapine in healthy young cats.
    Quimby JM; Gustafson DL; Samber BJ; Lunn KF
    J Vet Pharmacol Ther; 2011 Aug; 34(4):388-96. PubMed ID: 20969604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics of mirtazapine in cats with chronic kidney disease and in age-matched control cats.
    Quimby JM; Gustafson DL; Lunn KF
    J Vet Intern Med; 2011; 25(5):985-9. PubMed ID: 21985134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single and multiple dose pharmacokinetics of a novel mirtazapine transdermal ointment in cats.
    Buhles W; Quimby JM; Labelle D; Williams VS
    J Vet Pharmacol Ther; 2018 Oct; 41(5):644-651. PubMed ID: 30004120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mirtazapine as an appetite stimulant and anti-emetic in cats with chronic kidney disease: a masked placebo-controlled crossover clinical trial.
    Quimby JM; Lunn KF
    Vet J; 2013 Sep; 197(3):651-5. PubMed ID: 23838205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of compounded transdermal mirtazapine as an appetite stimulant in cats with chronic kidney disease.
    Quimby JM; Benson KK; Summers SC; Saffire A; Herndon AK; Bai S; Gustafson DL
    J Feline Med Surg; 2020 Apr; 22(4):376-383. PubMed ID: 31161850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited sampling pharmacokinetics of subcutaneous ondansetron in healthy geriatric cats, cats with chronic kidney disease, and cats with liver disease.
    Fitzpatrick RL; Wittenburg LA; Hansen RJ; Gustafson DL; Quimby JM
    J Vet Pharmacol Ther; 2016 Aug; 39(4):350-5. PubMed ID: 26667224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug exposure and clinical effect of transdermal mirtazapine in healthy young cats: a pilot study.
    Benson KK; Zajic LB; Morgan PK; Brown SR; Hansen RJ; Lunghofer PJ; Wittenburg LA; Gustafson DL; Quimby JM
    J Feline Med Surg; 2017 Oct; 19(10):998-1006. PubMed ID: 27613493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mirtazapine toxicity in cats: retrospective study of 84 cases (2006-2011).
    Ferguson LE; McLean MK; Bates JA; Quimby JM
    J Feline Med Surg; 2016 Nov; 18(11):868-874. PubMed ID: 26228539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind, placebo-controlled, randomized study to evaluate the weight gain drug, mirtazapine transdermal ointment, in cats with unintended weight loss.
    Poole M; Quimby JM; Hu T; Labelle D; Buhles W
    J Vet Pharmacol Ther; 2019 Mar; 42(2):179-188. PubMed ID: 30506924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appetite-stimulating effect of gabapentin vs mirtazapine in healthy cats post-ovariectomy.
    Fantinati M; Trnka J; Signor A; Dumond S; Jourdan G; Verwaerde P; Priymenko N
    J Feline Med Surg; 2020 Dec; 22(12):1176-1183. PubMed ID: 32462966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appetite Stimulant and Anti-Emetic Effect of Mirtazapine Transdermal Ointment in Cats Affected by Lymphoma Following Chemotherapy Administration: A Multi-Centre Retrospective Study.
    Ferro L; Ciccarelli S; Stanzani G; Nappi L; Angelini F; Leo C
    Animals (Basel); 2022 Jan; 12(2):. PubMed ID: 35049778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid composition of hepatic and adipose tissues from normal cats and from cats with idiopathic hepatic lipidosis.
    Hall JA; Barstad LA; Connor WE
    J Vet Intern Med; 1997; 11(4):238-42. PubMed ID: 9298479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of pioglitazone in lean and obese cats.
    Clark MH; Hoenig M; Ferguson DC; Dirikolu L
    J Vet Pharmacol Ther; 2012 Oct; 35(5):428-36. PubMed ID: 22612529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of mirtazapine.
    Timmer CJ; Sitsen JM; Delbressine LP
    Clin Pharmacokinet; 2000 Jun; 38(6):461-74. PubMed ID: 10885584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro hepatic metabolism of mefloquine using microsomes from cats, dogs and the common brush-tailed possum (Trichosurus vulpecula).
    Izes AM; Kimble B; Norris JM; Govendir M
    PLoS One; 2020; 15(4):e0230975. PubMed ID: 32287278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of tacrolimus after multidose oral administration and efficacy in the prevention of allograft rejection in cats with renal transplants.
    Kyles AE; Gregory CR; Craigmill AL; Griffey SM; Jackson J; Stanley SD
    Am J Vet Res; 2003 Jul; 64(7):926-34. PubMed ID: 12856780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of ketoconazole on the pharmacokinetics of cyclosporine A in cats.
    McAnulty JF; Lensmeyer GL
    Vet Surg; 1999; 28(6):448-55. PubMed ID: 10582742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in adipokines in feline hepatic lipidosis.
    Mazaki-Tovi M; Abood SK; Segev G; Schenck PA
    J Vet Intern Med; 2013; 27(2):242-9. PubMed ID: 23480841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of Single Oral Dose Extended-Release Levetiracetam in Healthy Cats.
    Barnard L; Barnes Heller H; Boothe DM
    J Vet Intern Med; 2018 Jan; 32(1):348-351. PubMed ID: 29114943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.